Sibling Oocyte Study of Medium for In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) With no Human Serum Albumine

Sykehuset Telemark

Overview

The purpose of this study is to determine if a new medium with no human serum albumine added is as good as the media conventionally used for IVF/ICSI.

Cells attained in IVF/ICSI procedures are kept in a medium that nurture the cells. Until now all such media have contained human serum albumine. The purpose of this study is to determine if a new medium with no human serum albumine added is as good as the media conventionally used for IVF/ICSI.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Conditions

In Vitro Fertilization Infertility

Interventions

Medium with no human serum albumine addedOTHER

See above

Conventional mediumOTHER

See above

Eligibility

Sex: ALLMin age: 18 YearsMax age: 38 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Couples seeking IVF/ICSI. * Female under 38 years of age. * No more than two previous IVF/ICSI treatments without pregnancy. * Regular menstruation periods. * No endocrine disease that requires treatment in the female. * BMI below 30 in the female. * At least 8 mature follicles upon monitoring or 6 MII oocytes upon ICSI. * Written informed consent. Exclusion Criteria: * Low responders to FSH. * Females in danger of developing OHSS. * Sperm sample below ICSI-quality.

Locations (1)

Fertilitetsklinikken Sør

Porsgrunn, Telemark, Norway

Outcomes

Primary Outcomes

Fertilization

Time frame: 24 hours

Cleavage

Time frame: 48 hours

Embryo score

Time frame: 48 hours

Embryos used

Time frame: 48 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.